Skip to content

iSert Intraocular Lens 250 (clear), +6.00DRecalls & reported problems

Hoya Medical Singapore Pte. Ltd. · Class 3 · Implant

All models of iSert Intraocular Lens (69)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04547480480503), received between Jul 12, 2022 and Jul 12, 2022 — classified as 1 injury.

The most frequently reported specific device problem is “Device Appears to Trigger Rejection” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Device Appears to Trigger Rejection1

Patient problems

  • Uveitis1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 12, 2022Device Appears to Trigger Rejection; Device Appears to Trigger Rejection

    REPORTED CASE OF INFLAMMATION (B)(6). (B)(6) 2022: MANUFACTURER'S FIRST DATE OF AWARENESS. THE IOL WAS IMPLANTEDON (B)(6) 2022. THE INFLAMMATION WAS NOTED 3 WEEKS LATER. PATIENT WAS TREATED WITH STEROIDS AND ANTIBIOTICS FOR 3 WEEKS RESOLUTION OF INFLAMMATION WAS NOTED ON (B)(6) 2022 (B)(6) 2022: AUTHORIZED COUNTRY REPRESENTATIVE ASSESSED AS A REPORTABLE EVENT TO COFEPRIS BY END OF YEAR.

    Patient problems: Uveitis

    MAUDE report 14989195 ↗

Other Intraocular Lens devices

All Intraocular Lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page